Human placental Feγ-binding proteins in the maternofetal transfer of IgG

APMIS, Supplement

Volumn 104, Issue 64, 1996, Pages 5-36

  Kristoffersen, Binar Klæboe ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; LIPOCORTIN 2; CARRIER PROTEIN; FC RECEPTOR; PLACENTA PROTEIN;

CONTROLLED STUDY; FETUS; HUMAN; HUMAN TISSUE; IMMUNOBIOLOGY; NEWBORN; PLACENTAL TRANSFER; PRIORITY JOURNAL; REVIEW; TROPHOBLAST; ANIMAL; FEMALE; FETOMATERNAL TRANSFUSION; IMMUNOLOGY; METABOLISM; PREGNANCY;

ANIMALS; CARRIER PROTEINS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY PROTEINS; RECEPTORS, IGG;

EID: 0030333556     PISSN: 0903465X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (375)

1. Abrahamson DR, Powers A, Rodewald R. Intestinal absorption of immune complexes by neonatal rats: a route of antigen transfer from mother to young. Science 1979; 206 (4418):567-569.
2. Abrahamson DR, Rodewald R. Evidence for the sorting of endocytic vesicle contents during the receptor-mediated transport of IgG across the newborn rat intestine. J. Cell Biol. 1981; 91:270-280.
3. Aherne W, Dunill MS. Quantitative aspects of placental structure. J Path Bact 1966; 91:123-139.
4. Ahouse JJ, Hagerman CL, Mittal P, et al. Mouse MHC class I-like Fc receptor encoded outside the MHC. J-Immunol 1993; 151 (11):6076-6088.
5. Amemiya K, Karachi H, Adachi H, et al. Involvement of epidermal growth factor (EGF)/EGF receptor autocrine and paracrine mechanism in human trophoblast cells: functional differentiation in vitro. J Endocrinol 1994; 143 (2):291-301.
6. Amslutz E. Beobachtungen über die reifung der chorionzotten in der menschlichen placenta mit besonderer berücksichtigung der epithelplatten. Acta anat (Basel) 1960; 42:12-30.
7. Anderson CL. Isolation of the receptor for IgG from a human monocyte cell line (U937) and from human peripheral blood monocytes. J Exp Med 1982; 156 (6):1794-1806.
8. Anderson CL, Abraham GN. Characterization of the Fc receptor for IgG on a human macrophage cell line, U937. J Immunol 1980; 125 (6):2735-2741.
9. Anderson CL, Looney RJ. Human Leukocyte IgG Fc receptors. Immunol. Today 1986; 7:264-266.
10. Anderson CL, Looney RJ, Culp DJ, et al. Alveolar and peritoneal macrophages bear three distinct classes of Fc receptors for IgG. J Immunol 1990; 145 (1):196-201.
11. Anneren G, Magnusson CG, Lilja G, Nordvall SL. Abnormal serum IgG subclass pattern in children with Down's syndrome. Arch Dis Child 1992; 67 (5):628-31.
12. Aristotle. On the generation of animals. 350BC:Book II, chapter 7.
13. Attwood HD, Park WW. Embolism to the lungs by trophoblast. J Obstet Gynaecol Br Commonw 1961; 68:611-617.
14. Austgulen R, Espevik T, Mecsei R, Scott H. Expression of receptors for tumor necrosis factor in human placenta at term. Acta Obstet. Gynecol. Scand. 1992; 71:417-424.
15. Balfour AH, Jones EA. The binding of plasma proteins to human placental cell membranes. Clin. Sci. Mol. Med. 1977; 52:383-394.
16. Balfour AH, Jones EA. Properties of receptors for IgG on human placental cell membranes. Int. Archs Allergy appl. Immunol. 1978; 56:435-442.
17. Bangham DR, Hobbs KR, Terry RJ. Selective placental transfer of serum proteins in the rhesus. Lancet 1958; 2:351-354.
18. Barton GJ, Newman RH, Freemont PS, Crumpton MJ. Amino acid sequence analysis of the annexin super-gene family of proteins. Eur. J. Biochem. 1991; 198:749-760.
19. Beckman G, Beckman L, Hohn S, Sikstrom C, Wennberg C. Placental alkaline phosphatase types and transplacental IgG transport. Hum Hered 1995; 45 (1):1-5.
20. Beer AE, Billingham RE. The embryo as a transplant. Sci Am 1974; 230 (4):36-46.
21. Berryman M. Rodewald R. b2-Microglobulin co-distributes with the heavy chain of the intestinal IgG-Fc receptor throughout the transepithelial transport pathway of the neonatal rat. J Cell Sci 1995; 108 (Part 6):2347-2360.
22. Blanchi R, Giambanco I, Ceccarelli P, Pula G, Donato R. Membrane-bound annexin V isoforms (CaBP33 and CaBP37) and annexin VI in bovine tissues behave like integral membrane proteins. FEBS Lett 1992; 296 (2):158-162.
23. Black CM, Plikaytis BD, Wells TW. et al Two-site immunoenzymometric assays for serum IgG subclass infant/maternal ratios at full-term. J.Immunol. Methods 1988; 106:71-81.
24. Blackwell GJ. Specificity and inhibition of glucocorticoid-induced macrocortin secretion from rat peritoneal macrophages. Br. J. Pharmacol. 1983; 79:587-594.
25. 2+-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins. Biochem J 1990; 266 (1):195-200.
26. Blumberg RS, Koss T, Story CM, et al. A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes. J Clin Invest 1995; 95 (5):2397-2402.
27. Bomsel M, Prydz K, Parton RG, Gruenberg J. Simons K. Endocytosis in filter-grown Madin-Darby canine kidney cells. J Cell Biol 1989; 109 (6 Pt 2):3243-3258.
28. Booth AG, Olaniyan RO, Vanderpuye OA. An improved method for the preparation of human placental syncytiotrophoblast microvilli. Placenta 1980; 1 (4):327-336.
29. Booth AG, Wilson MJ. Human placental coated vesicles contain receptor-bound transferrin. Biochem J 1981; 196 (1):355-362
30. Boyd JD, Hamilton WJ. The human placenta. Cambridge: W Heffer & sons ltd, 1970.
31. Boyko V. Mudrak O, Svettova M, Negishi Y, Ariga H, Tomilin N. A major cellular substrate for protein kinases, annexin II, is a DNA-binding protein. FEBS Lett. 1994; 345:139-142.
32. Brambell FW. The transmission of immune globulins from the mother to the foetal and newborn young. Proc Nutr Soc 1969; 28(1):35-41.
33. Brambell FWR. The transmission of passive immunity from mother to young and the catabolism of immunoglobulins. Lancet 1966; ii:1087-1093.
34. Brambell FWR. The transmission of passive immunity from mother to young. 1970. (Neuberger A, Tatum EL, eds. Frontiers of biology; vol 18).North-Holland Publishing Company, Amsterdam.
35. Brambell FWR, Halliday R. The route by which passive immunity is transmitted from mother to foetus in the rat. Proc R Soc Lond 1956; 145:170-178.
36. Brambell FWR, Halliday R, Brierley J, Hemmings WA. Transference of passive immunity from mother to young. Lancet 1954; 1:964-965.
37. Brambell FWR, Hemmings WA. The passage into the embryonic yolk-sac cavity of maternal plasma proteins in rabbits. J Physiol 1949; 108:177-185.
38. Brambell FWR, Hemmings WA, Morris IG. A theoretical model of γ-globulin catabolism. Nature 1964; 203 (4952):1352-1355.
39. Brambell FWR, Hemmings WA, Oakley CL. Porter RR. The relative transmission of the fractions of papain hydrolysed homologous γ-globulin from the uterine cavity to the foetal circulation in the rabbit. Proc R Soc Lond B 1960; 151:478-482.
40. Bright NA, Ockleford CD. Heterogeneity of Fey receptor-bearing cells in human term amniochorion. Placenta. 1994; 15:247-255.
41. Bright NA, Ockleford CD. Cytotrophoblast cells: A barrier to maternofetal transmission of passive immunity? J Histochem Cytochem 1995; 43 (9):933-944.
42. Bright NA, Ockleford CD. Ultrastructural distribution of endogenous immunoglobulin- G in human term amniochorion. Cell Tissue Res 1995; 281 (2):367-374.
43. Bright NA, Ockleford CD, Anwar M. Ontogeny and distribution of Fey receptors in the human placenta. Transport or immune surveillance? J. Anat. 1994; 184:297-308.
44. Brock DJ, Barron L, Holloway S, Liston WA, Hillier SG, Seppala M. First-trimester maternal serum biochemical indicators in Down syndrome. Prenat Diagn 1990; 10 (4):245-251.
45. Brown PJ, Johnson PM. Fey-receptor activity of isolated human placental syncytiotrophoblast plasma membrane. Immunol 1981; 42 (2):313-319.
46. Brown PJ, Johnson PM. The interaction of Sepharose-immobilised IgG with isolated human placental syncytiotrophoblast plasma membrane vesicles. J Reprod Immunol 1981; 3 (6):351-358.
47. Bryan EM. IgG deficiency in association with placental oedema. Early Hum Dev 1977; 1(2):133-143.
48. Buliner JN, Longfellow M, Ritson A. Leukocytes and resident blood cells in endometrium. Ann N Y Acad Sci 1991; 622:57-68.
49. Burgoyne RD, Cambray Deakin MA, Norman KM. Developmental regulation of tyrosine kinase substrate p36 (calpactin heavy chain) in rat cerebellum. J Mol Neurosci 1989; 1(1):47-54.
50. Burgoyne RD, Geisow MJ. The annexin family of calciumbinding proteins. Cell Calcium 1989; 10:1-10.
51. Burmeister WP, Gastinel LN, Simister NE, Slum ML, Bjorkman PJ. Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor. Nature 1994; 372 (6504):336-43.
52. Burmeister WP, Huber AH, Bjorkman PJ. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 1994; 372 (6504):379-383.
53. Burns AL, Magendzo K, Shirvan A, et al. Calcium channel activity of purified human synexin and structure of the human synexin gene. Proc Natl Acad Sci U S A 1989; 86 (10):3798-3802.
54. Burns AL, Magendzo K, Srivastava M, et al. Human synexin (annexin VII) polymorphisms: tissue specificity and expression in Escherichia coli. Biochem Soc Trans 1990; 18 (6):1118-1121.
55. Burton GJ. The fine structure of the human placental villus as revealed by scanning electron microscopy. Scanning Microsc 1987; 1(4):1811-1828.
56. Catty D. Seger R, Drew R, Ströder J, Metze H. IgG-subclass concentrations in cord sera from premature, full term and small-for-dates babies. Eur J Pediat 1977; 125:89-96.
57. Cederqvist LL. Ewool LC. Bonsnes RW, Litwin SD. Detectability and pattern of immunoglobulins in normal amniotic fluid throughout gestation. Am J Obstet Gynecol 1978;130 (2):220-224.
58. Cederqvist LL, Spigelman S, Litwin SD. Decreased cord blood IgM and IgA in trisomy 21. Am J Reprod Immunol 1981; 1(2):62-64.
59. Cervi PL, Feigliery C. IgG subclasses in foetal cord and maternal serum: associations with infections in infancy and smoking in pregnancy. J Clin Lab Immunol 1991; 34 (1):23-30.
60. Chen JM, Sheldon A, Pincus MR. Structure-function correlations of calcium binding and calcium channel activities based on 3-dimensional models of human annexins I, II, IILVand VII. J. Biomol. Struct. Dyn. 1993; 10:1067-1089.
61. Chiang Y, Schneiderman MH, Vishwanatha JK. Annexin II expression is regulated during mammalian cell cycle. Cancer Res. 1993; 53:6017-6021.
62. Christoffersen AK. La superficie des villosités choriales du placenta á la fin de la grossesse. (Étude d'histologie quantitative). C r Séanc Soc Biol 1934; 117:641-644.
63. Cluing CY. Erickson HP. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J. Cell Biol. 1994; 126:539-548.
64. Cirino G, Peers SH, Flower RJ, Browning JL, Pepinsky RB. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. Proc. Natl .Acad. Sci. U.S.A. 1989; 86:3428-3432.
65. Clark GB, Roux SI Annexins of plant cells. Plant Physiol 1995; 109 (4):1133-1139.
66. Cole SP, Pinkoski MJ, Bhardwaj G, Deeley RG. Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line. Br. J. Cancer 1992; 65:498-502.
67. Colten HR. Ontogeny of the human complement system: in vitro biosynthesis of individual complement components by fetal tissues. J Clin Invest 1972; 51 (4):725-730.
68. Creutz CE. The annexins and exocytosis. Science 1992; 258:924-931.
69. 2+. J Biol Chem 1983; 258 (23):14664-14674.
70. Creutz CE, Pazoles CJ, Pollard HB. Identification and purification of an adrenal medullary protein (synexin) that causes calcium-dependent aggregation of isolated chromaffin granules. J Biol Chem 1978; 253 (8):2858-2866.
71. Croxtall JD, Flower RJ. Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. Proc. Natl Acad. Sci. U.S.A. 1992; 89:3571-3575.
72. Croxtall JD, Pollard JW, Carey F, Forder RA, White JO. Colony stimulating factor-1 stimulates Ishikawa cell proliferation and lipocortin II synthesis. J Steroid Biochem Mol Biol 1992; 42 (2):121-129.
73. Dancis J, Lind J, Oratz M, Smolens J, Vara P. Placental transfer of proteins in human gestation. Am J Obst Gynec 1961; 82(1):167-171.
74. Davidson FF, Dennis EA, Powell M, Glenney JRJ. Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids. J. Biol Chem. 1987; 262:1698-1705.
75. Davis RG, Vishwanatha JK. Detection of secreted and intracellular annexin II by a radioimrminoassay. J Immunol Meth 1995; 188:91-95.
76. de la Fuente M, Parra AV.Vesicle aggregation by annexin I: Role of a secondary membrane binding site. Biochemistry 1995; 34 (33):10393-10399.
77. Degenne D, Khalfoun B, Bardos P. in vitro inhibitory effect of human syncytiotrophoblast plasma membranes on the cytolytic activities of CTL and NK cells. Am J Reprod Immunol Microbiol 1986; 12 (4):106-110.
78. Desoye G, Hartmann M, Blaschitz A, et al Insulin receptors in syncytiotrophoblast and fetal endothelium of human placenta. Immunohistochemical evidence for developmental changes in distribution pattern. Histochemistry 1994; 101 (4):277-285.
79. Dimmette JE. Studies of human pregnancy. I. Immunoglobulins attached to the trophoblast. Obstet Gynecol 1976; 47 (6):730-732.
80. Doellgast GJ, Benirschke K. Placental alkaline phosphatase in hominidae. Nature 1979; 280:601-602.
81. Donato R. Perspectives in S-100 protein biology. Review article. Cell Calcium 1991; 12 (10):713-726.
82. Douglas GW, Tliomas L, Carr M, Cullen NM, Morris R.Ttophoblast in the circulating blood during pregnancy. Am J Obstet Gynecol 1959; 78 (5):960-973.
83. Down JA, Kawakami M, Klein MH, Dorrington KJ. Proteins associated with activity of Fc receptors on isolated human placental syncytiotrophoblast microvillous plasma membranes. Placenta. 1989; 10:227-246.
84. Drust DS, Creutz CE. Aggregation of chromaffin granules by calpactin at micromolar levels of calcium. Nature 1988; 331 (6151):88-91.
85. Eberhard DA, Brown MD, Vandenberg SR. Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and pll subunits), IV and VI in the human hippocampus. Am J Pathol 1994; 145:640-649.
86. Ehrlich P. Über Immunität durch Vererbung und Säugung. Z. Hyg. Infect. Kr. 1892; 12:183-203.
87. Einhorn MS. Granoff DM, Nahm MH, Quinn A, Shackelford PC. Concentrations of antibodies in paired maternal and infant sera: relationship to IgG subclass. J Pediatr 1987; 111 (5):783-788.
88. Emans N, Gorvel JP, Walter C, et al Annexin II is a major component of fusogenic endosomal vesicles. J.Cell Biol. 1993; 120:1357-1369.
89. Erikson E, Tomasiewicz HG, Erikson RL. Biochemical characterization of a 34-kilodalton normal cellular substrate of pp60v-src and an associated 6-kilodalton protein. Mol Cell Biol 1984; 4(1):77-85.
90. Esterman AL, Dancis J, Lee JD, Rindler AM Two mechanisms for IgG uptake in cultured human trophoblast: Evidence for a novel high affinity Fc receptor. Pediatr Res 1995; 38(1):1-6.
91. Faulk WP, Galbraith GM. Trophoblast transferrin and transferrin receptors in the host-parasite relationship of human pregnancy. Proc R Soc Lond B Biol Sci 1979; 204 (1154):83-97.
92. Faulk WP, Jarret R, Keane M, Johnson PM, Boackle RJ. Immunological studies of human placentae: complement components in immature and mature chorionic villi. Clin Exp Immunol 1980; 40 (2):299-305.
93. Faulk WP, Johnson PM. Immunological studies of human placentae: identification and distribution of proteins in mature chorionic villi. Clin Exp Immunol 1977; 27 (2):365-375.
94. Faulk WP, Loghem Ev, Stickler GB. Maternal antibody to fetal light chain (Inv) antigens. Am J Med 1974; 56 (3):393-397.
95. Faulk WP, Temple A. Distribution of b-2 microglobulin and HLA in chorionic villi of human placentae. Nature 1976; 262:799-802.
96. Feinberg BB, Tan NS, Walsh SW, Brath PC, Gonik B. Progesterone and estradiol suppress human mononuclear cell cytotoxicity. J Reprod Immunol 1992; 21 (2):139-148.
97. Ferreira A, Garcia Rodrigiiez MC, Omenaca F, et al Soluble class I histocompatibility antigens (s-HLA) and b2-microglobulin at delivery. Clin Exp Immunol 1991; 84 (1):167-169.
98. Fischl R, Wunscheim Ov. Über Schutzkörper im Blute des Neugeborenen; das Verhalten de Blutserums des Neugeborenen gegen Diphteriebacillen und Diphteriegift nebst kritischen Bemerkungen zur humoralen Immunitätstheorie. Z. Heilk 1895; 16:429-482.
99. Flaherty MJ, West S, Heimark RL, Fujikawa K. Tait JE Placental anticoagulant protein-I: measurement in extracellular fluids and cells of the hemostatic system. J. Lab. Clin. Med. 1990; 115:174-181.
100. Fleit HB, Wright SD, Durie CJ, Valinsky JE, Unkeless JC. Ontogeny of Fc receptors and complement receptor (CR3) during human myeloid differentiation. J Clin Invest 1984; 73 (2):516-525.
101. 10L Fleit HB, Wright SD, Unkeless JC. Human neutrophil Fcg receptor distribution and structure. Proc Natl Acad Sci U S A 1982; 79 (10):3275-3279.
102. Fletcher J, Suter PE. The transport of iron by the human placenta. Clin Sci 1969; 36 (2):209-220.
103. Flower RJ. Lipocortin. Prog .Clin. Biol. Res. 1990; 349:11-25.
104. Fox H. The incidence and significance of vasculo-syncytial membranes in the human placeta. J Obstet Gynaec Br Commonw 1967; 74:28-33.
105. Franklin EC, Kunkel HG. Comparative levels of high molecular weight (19S) γ globulin in maternal and umbilical cord sera. J Lab clin Med 1958; 52:724-727.
106. Freda VJ. Placental transfer of antibodies in man. Am J Obstet Gynec 1962; 84 (2):1756-1777.
107. Frohlich M, Motte P, Calvin K, Takahashi H, Wands J, Ozturk M. Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma. Mol Cell Biol 1990; 10 (6):3216-3223.
108. Funakoshi T, Heimark RL, Hendrickson LE, McMullen BA, Fujikawa K. Human placental anticoagulant protein: isolation and characterization. Biochemistry 1987; 26 (17):5572-5578.
109. Furuhashi M, Seo H. Mizutani S, Narita O, Tomoda Y, Matsui N. Expression of low density lipoprotein receptor gene in human placenta during pregnancy. Mol Endocrinol 1989; 3 (8):1252-1256.
110. Garcia-Lloret MI. Morrish DW, Wegmann TG, Honore L, Turner AR. GuilbertLJ. Demonstration of functional cytokine-placental interactions: CSF-1 and GM-CSF stimulate human cytotrophoblast differentiation and peptide hormone secretion. Exp. Cell Res. 1994; 214:46-54.
111. Gasparoni A, Avanzini A, Ravagni Probizer F, Chirico G. Rondini G, Seven F. IgG subclasses compared in maternal and cord serum and breast milk. Arch Dis Child 1992; 67 (1 Spec No):41-43.
112. Gastinel LN, Simister NE, Bjorkman PJ. Expression and crystallization of a soluble and functional form of an Fc receptor related to class I histocompatibility molecules. Proc Natl Acad Sci U S A 1992; 89 (2):638-642.
113. Gerke V, Weber K. Identity of p36K phosphorylated upon Rous sarcoma virus transformation with a protein purified from brush borders; calcium-dependent binding to nonerythroid spectrin and F-actin. EMBO J. 1984; 3:227-233.
114. Gerke V, Weber K. Calcium-dependent conformational changes in the 36-kDa subunit of intestinal protein I related to the cellular 36-kDa target of Rous sarcoma virus tyrosine kinase. J Biol Chem 1985; 260 (3):1688-1695.
115. Gerke V, Weber K. The regulatory chain in the p36-kd substrate complex of viral tyrosine-specific protein kinases is related in sequence to the S-100 protein of glial cells. Embo J1985; 4 (11):2917-2920.
116. 2-microglobulin-deficient mice. Eur. J. Immunol. 1996; 26:690-696.
117. Giddy MJ, Hay DL, Horacek I. Amniotic fluid enzymes in pregnancies with trisomy 21. Prenat Diagn 1989; 9 (11):769-775.
118. Gitlin D, Biasucci A. Development of γG, γA, γM, βlc/βla, C'l esterase, hemopexin, haptoglobin, fibrinogen, plasminogen, α2-antitrypsin, orosomucoid, β-lipoprotein, α2-macroglobulin, and prealbumin in the human conceptus. J. Clin Invest 1969; 48:1433-1446.
119. Gillin D, Kumate J, Morales C. Metabolism and maternofetal transfer of growth hormone in the pregnant woman at term. J Clin Endocr 1965; 25:1599-1608.
120. Gitlin D. Kumate J, Urrusti J, Morales C. The selectivity of the human placenta in the transfer of plasma proteins from mother to fetus. J. Clin Invest 1964; 43 (10):1938-1951.
121. Gillin D, Rosen FS. Michael JG. Transient 19Sγl-globulin deficiency in the newborn, and its significance. Pediatrics 1963; 31:197-208.
122. Gitlin JD, Gillin D. Protein binding by specific receptors on human placenta, murine placeta, and suckling murine intestine in relation to protein transport across these tissues. J Clin Invest 1974; 54:1155-1166.
123. 2+ binding by the 36-kDa tyrosine kinase substrate (calpactin) and its 33-kDa core. J Biol Chem 1986; 261 (16):7247-7252.
124. 2+-dependent manner. Proc Natl Acad Sci USA 1986; 83 (12):4258-4262.
125. Glenney JR Jr., Boudreau M. Galyean R. Hunter T, Tack B. Association of the S-100-related calpactin I light chain with the NH2-terminal tail of the 36-kDa heavy chain. J Biol Chem 1986; 261 (23):10485-10488.
126. 2+-regulated phospholipid- and actin-binding proteins isolated from lung and placenta. J. Cell. Biol. 1987; 104:503-511.
127. Goldstein DJ, Harris H. Human placental alkaline-phosphatase differs from that of other species. Nature 1979; 280:602-604.
128. Goto S, Hoshino M, Tomoda Y, Ishizuka N. Immunoelectron microscopy of the human chorionic villus in search of blood group A and B antigens. Lab Invest 1976; 35 (6):530-536.
129. Could KL, Woodgett JR, Isacke CM, Hunter T. The proteintyrosine kinase substrate p36 is also a substrate for protein kinase C in vitro and in vivo. Mol Cell Biol 1986; 6 (7):2738-2744.
130. Goulding NJ, Guyre PM. Impairment of erythrocyte-antibody rosette formation by human lipocortin 1 on human leucocytes. Biocem. soc. trans. 1988; 16:730-731.
131. Coulding NJ, Guyre PM. Glucocorticoids, lipocortins and the immune response. Curr. Opin. Immunol. 1993; 5:108-113.
132. Goulet F, Moore KG, Sartorelli AC. Glycosylation of annexin I and annexin II. Biochem. Biophys. Res. Commun. 1992; 188:554-558.
133. Gregg AR, Weiner CP. "Normal" umbilical arterial and venous acid-base and blood gas values. Clin. Obstet. Gynecol. 1993; 36(1):24-32.
134. Griffiths GD, Kershaw D, Booth AG. Rabbit peroxidase-antiperoxidase complex (PAP) as a model for the uptake of immunoglobulin G by the human placenta. Histochem J1985; 17 (8):867-881.
135. Haigler HT, Christmas P. Annexin 1 is secreted by the human prostate. Biochem. Soc. Trans. 1990; 18:1104-1106.
136. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J. Biol. Chem. 1994; 269:21191-21197.
137. Halliday R. Prenatal and postnatal transmission of passive immunity to young rats. Proc. R. Soc. Lond. B 1955; 144:427-430.
138. Harder T. Gerke KThe subcellular distribution of early endosomes is affected by the annexin II2p11 (2) complex. J. Cell Biol. 1993; 123:1119-1132.
139. Harris H. The human alkaline phosphatases: what we know and what we don't know. Clin Chim Acta 1990; 186 (2):133-150.
140. Hay FC, Hull MGR, Torrigiani G. The transfer of human IgG subclasses from mother to foetus. Clin. exp. Immonol. 1971; 9:355-358.
141. Heape W. Preliminary note on the transplantation and growth of mammalian ova within a uterine foster mother. Proc. R. Soc. London (Biol) 1891; 48:457-458.
142. Heizmann CW. Calcium-binding proteins: basic concepts and clinical implications. Gen. Physiol. Biophys. 1992; 11:411-425.
143. Holmes CH, Simpson KL, Okada H, et al. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur. 1 Immunol. 1992; 22:1579-1585.
144. Huang KS, Wallner BP, Mattaliano RJ, et al. Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor/kinase. Cell 1986; 46:191-199.
145. Hubaishy I, Jones PG, Bjorge J, et al. Modulation of annexin II tetramer by tyrosine phosphorylation. Biochemistry 1995; 34 (44):14527-14534.
146. Huber R, Romisch J, Paques EP. The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes. Embo J 1990; 9 (12):3867-3874.
147. Huebers HA, Finch CA.The physiology of transferrin and transferrin receptors. Physiol Rev 1987; 67 (2):520-582.
148. Huizinga TW, Kerst M, Nuyens JH, et al. Binding characteristics of dimeric IgG subclass complexes to human neutrophils. J Immunol 1989; 142 (7):2359-2364.
149. Hulstaert CE, Torringa JL, Koudstaal J, Hardonk MJ, Molenaar I, The characteristic distribution of alkaline phosphatase in the full-term human placenta. An electron cytochemical study. Gynecol Invest 1973; 4 (1):23-30.
150. Hunt JS. Immunobiology of pregnancy. Curr Opin Immunol 1992; 4 (5):591-596.
151. Hunziker W, Mellman I. Expression of macrophage-lymphocyte Fc recepotrs in Madin-Darby Canine Kidney cells: polarity and transcytosis differ for iosforms with or without coated pit localization domains. J Cell Biol 1989; 109 (6):3291-3302.
152. Iioka H, Akada S, Yainada Y, et al. Platelet aggregation inhibiting activity of human placental chorioepithelial brush border membrane vesicles; the role of alkaline phosphatase. Placenta. 1994; 15:291-298.
153. Ind TE, Iles RK, Wathen NC, Carvalho C, Campbell J, Chard T. Second trimester amniotic fluid placental alkaline phosphatase levels are low in Down's syndrome but not in other fetal abnormalities. Early Hum. Dev. 1994; 37:39-44.
154. Indik ZK, Park JG, Hunter S, Schreiber AD. The molecular dissection of Fey receptor mediated phagocytosis. Blood 1995; 86 (12):4389-4399.
155. 2-microglobulin-associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice. J Immunol 1995; 154 (12):6246-6251.
156. Israel EJ, Simister N, Freiberg E, Caplan A, Walker WA. Immunoglobulin G binding sites on the human foetal intestine: a possible mechanism for the passive transfer of immunity from mother to infant. Immunology 1993; 79 (1):77-81.
157. Israel EJ,Wilsker DF, Hayes KC, Schoenfeld D, Simister NE. Increased clearance of IgG in mice that lack β-2-microglobulin: possible role of FcRn. In press.
158. Jalanko H, Heikinlieimo M, Ryynanen M, Ranta T, Aula P. Alkaline phosphatase activity in amniotic fluid in pregnancies with fetal disorders. Prenat Diagn 1983; 3 (4):303-309.
159. Jindal HK, Clianey WG, Anderson CW, Davis RG, Vishnanatha JK. The protein-tyrosine kinase substrate, calpactin I heavy chain (p36), is part of the primer recognition protein complex that interacts with DNA polymerase alpha. J Biol Chem 1991; 266 (8):5169-5176.
160. Johnson PM. Reproductive and maternofetal relations. In: Lachman PJ Peters, D.K., Rosen, F.S., Walport, M.I, ed. Clinical aspects of immunology. 5 ed. Blackwell Scientific Publications, 1993:Chapter 40, 755-767.
161. Johnson PM. Immunobiological characterization of the trophoblast-decidual interface in human pregnancy. In: Hunt JS, ed. Immunobiology of reproduction. New York: Springer Verlag, 1994:3-13. Sereno Symposia, Nonvell, Massachusetts, USA;
162. Johnson PM, Brown PJ, Slade MB. Identification ofsyncytiotrophoblast-associated IgG in term human placentae. J. Reprod. Immunol. 1982; 4:1-9.
163. Johnson PM, Faulk PW.Wang A-C. Immunological studies on human placentae: subclass and fragment specificity of binding of aggregated IgG by placental endothelial cells. Immunol 1976; 31:659-664.
164. Johnson PM, Faulk WP. Immunological studies of human placentae: identification and distribution of proteins in immature chorionic villi. Immunology 1978; 34 (6):1027-1035.
165. Johnson PM, Maire R. Membrane receptors for IgG in the human placenta. In: Hemmings WA, ed. Protein transmission through living membranes. 1 ed. Elsevier/North-Holland Biomedical Press, 1979:45-54.
166. Johnson PM, Trencher P, Faulk WP. Immunological studies of placentae: binding of complexed immunolglobulin by stromal enothelial cells. Clin Exp Immunol 1973; 22:133-138.
167. Johnsson N, Marriott G, Weber K. p36, the major cytoplasmic substrate of src tyrosine protein kinase, binds to its pll regulatory subunit via a short amino-terminal amphiphatic helix. EMBO J. 1988; 7:2435-2442.
168. Johnsson N, Nguyen Van P, Soling HD, Weber K. Functionally distinct serine phosphorylation sites of p36, the cellu. lar substrate of retroviral protein kinase; differential inhibition of reassociation with pll. Embo J 1986; 5 (13):3455-3460.
169. Johnsson N, Vandekerckhove J, Van Damme J, Weber AT. Binding sites for calcium, lipid and pll on p36, the substrate of retroviral tyrosine-specific protein kinases. FEBS Lett 1986; 198 (2):361-364.
170. Johnsson N, Weber K. Alkylation of cysteine 82 of p11 abolishes the complex formation with the tyrosine-protein kinase substrate p36 (annexin 2, calpactin 1, lipocortin 2). J. Biol .Chem. 1990; 265:14464-14468.
171. Johnston PA, Sudhof TC. Evolutionary conservation and structural determinants of the calelectrins (annexins). Biochem Soc Trans 1990; 18 (6):1097-1098.
172. Johnstone SA. Hiibaishy I, Waisman DM. Phosphorylation of annexin II tetramer by protein kinase C inhibits aggragation of lipid vesicles by the protein. J. Biol. Chem. 1992; 267:25976-25981.
173. Jones CJ, Fox H. Ultrastructure of the normal human placenta. Electron Microsc Rev 1991; 4 (1):129-178.
174. Jones CJP, FoxH. An ultrahistochemical study of the distribution of acid and alkaline phosphatases in placentae from normal and complicated pregnancies. J Pathol 1976; 118:143-151.
175. Jones EA, Waldmann TA. The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. J. Clin Invest 1972; 51:2916-2927.
176. Jones WR. Fetal and neonatal immunology. In: Scott JS, Jones WR, eds. Immunology of human reproduction. London, New York: Academic Press, grune & Stratton, 1976:127-167.
177. 2+-binding sites. Biochem. J. 1994; 298:553-559.
178. Kaliss W, Dagg MK. Immune response engendered in mice by multiparity. Transplant 1964; 2:416-425.
179. Kameda T, Koyama M, Matsuzaki N, Taniguchi T, Saji F, Tanizawa O. Localization of three subtypes of Fey receptors in human placenta by immunohistochemical analysis. Placenta. 1991; 12:15-26.
180. Kim EE, Wyckoff HW. Structure of alkaline phosphatases. Clin Chini Acta 1990; 186 (2):175-187.
181. Kim JK, Tsen MF, Ghetie V,Ward ES. Localization of the site of the murine IgGl molecule that is involved in binding to the murine intestinal Fc receptor. Eur J Immunol 1994; 24 (10):2429-34.
182. King BF. Absorption of peroxidase-conjugated immunoglobulin G by human placenta: an in vitro study. Placenta 1982; 3:395-406.
183. Kirsch T, Pfäffle M. Selective binding of anchorin CII (annexin V) to type II and X collagen and to chondrocalcin (C-propeptide of type II collagen). Implications for anchoring function between matrix vesicles and matrix proteins. FEBS Lett. 1992; 310:143-147.
184. Kliman HJ, Nestler JE. Sermasi E, Sanger JM, Strauss JF. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 1986; 118:1567-1582.
185. Kobayashi K, Blaser MJ, Brown WR. Identification of a unique IgG Fc binding site in human intestinal epithelium. J Immunol 1989; 143 (8):2567-2574.
186. Kohler PF, Farr RS. Elevation of cord over maternal IgG immunoglobuolin: evidence for an active placental transport. Nature 1966; 210:1070-1071.
187. Kojima K, Ogawa HK, Seno N. et al. Carbohydrate-binding proteins in bovine kidney have consensus amino acid sequences of annexin family proteins. J Biol Chem 1992; 267 (29):20536-20539.
188. Kristoffersen EK, Maire R. Local immunosuppression of syncytiotrophoblast microvilli in pregnancy. IX International Immunology Conference. San Francisco Abstract Book 1995:189.
189. Kristoffersen EK, Matre R. Co-localization of β2-microglobulin and IgG in human placental syncytiotrophoblasts. Eur. J. Immunol. 1996; 26:505-507.
190. Kristoffersen EK, Matre R. Co-localization of the neonatal Fc receptor and IgG in human placental term syncytiotrophoblasts. Eur. J. Immunol. 1996; 26:1668-1671.
191. Kristoffersen EK, Matre R. Surface annexin II on placental membranes of the fetomaternal interface. Am. J. Rep rod. Immunol. 1996; 36:141-149.
192. Kristoffersen EK, Matre R, Ulvestad E, Vedeler CA. A dotimmunobinding assay for the demonstration of soluble Fey receptors. J. Immunol. Methods 1994; 167:15-19.
193. Kristoffersen EK, Uhestad E, Bjorge L, Aarli Å. Matre R. Fey receptor activity of human placental annexin II. Scand. J. Immunol. 1994; 40:237-242.
194. Kristoffersen EK, Uhestad E, Vedeler CA, Matre R. Fey receptor heterogeneity in the human placenta. Scand. J. Immunol. 1990; 32:561-564.
195. Kube E, Becker T, Weber K, Gerke V. Protein-protein interaction studied by site-directed mutagenesis. Characterization of the annexin II-binding site on pll, a member of the S100 protein family. J. Biol. Chem. 1992; 267:14175-14182.
196. Kurlander RJ, Batker J. The binding of human immnoglobulin Gl monomer and small, covalently cross-linked polymers of immunoglobulin Gl to human peripheral blood monocytes and polymorphonuclear leukocytes. J. Clin. Invest. 1982; 69:1-8.
197. Landsteiner K, Mener AS. An agglutinable factor in human blood recognised by immune sera for Rhesus blood. Proc. Soc. Exp. Biol. (N.Y) 1940; 43:223.
198. Lang I, Hartmann M, Blaschitz A, Dohr G, Skofitsch G, Desoye G. Immunohistochemical evidence for the heterogeneity of maternal and fetal vascular endothelial cells in human full-term placenta. Cell Tissue Res 1993; 274 (2):211-218.
199. Lanman JT, Herod L. Homograft immunity in pregnancy. The placental transfer of cytotoxic antibody in rabbits. J Exp Med 1965; 122 (3):579-586.
200. Larsson M, Majeed M, Stendahl O, Magnusson K-E. Ernst JD. Forsum U. Mobilization of annexin Vduring the uptake of DNP-albumin by human dendritic cells. APMIS 1995; 103:855-861.
201. Le Bouteiller P, Rodriguez A-M, Mallet V, Girr M, Guillaudetix T, Lenfant F. Placental expression of HLA class I genes. Am J. Reprod. Immunol. 1996; 35:216-225.
202. Leach L, Eaton BM, Firth JA. Contractor SF. Immunogold localisation of endogenous immunoglobulin-G in ultrathin frozen sections of the human placenta. Cell Tissue Res. 1989; 257:603-607.
203. Leach L, Eaton BM, Firth JA, Contractor SF. Uptake and intracellular routing of peroxidase-conjugated immunoglobulin-G by the perfused human placenta. Cell Tissue Res. 1990; 261:383-388.
204. Leach L, Eaton BM, Firth JA, Contractor SF. Immunocytochemical and labelled tracer approaches to uptake and intracellular routing of immunoglobulin-G (IgG) in the human placenta. Histochem J1991; 23 (10):444-449.
205. Lee T. Lin Y, Mochitate F, Grinelle F. Stress-relaxation of fibroblasts in collagen matrices triggers ectocytosis of plasma membrane vesicles containing actin, annexins II and VI, and b-1 integrin receptors. J Cell Sci 1993; 105 (1):167-177.
206. Levine P, Stetson RE. An unusual case of intra-group agglutination. J. Amer. Med. Assoc. 1939; 113:126-127.
207. Lin C. Immunoelectron microscopic localization of immunoglobulin G in human placenta. Histochemistry 1980; 28:339-346.
208. Linnet-Jepsen P, Galatius-Jensen F. On the inheritance of the Gm serum group. Acta Genet 1958; 8:164-196.
209. Loh RK, Harth SC, Thong YH, Ferrante A. Immunoglobulin G subclass deficiency and predisposition to infection in Down's syndrome. Pediatr Infect Dis J1990; 9(8):547-551.
210. Luecke H, Chang BT, Mailliard WS, Schlaepfer DD. Haigler HT. Crystal structure of the annexin XII hexamer and implications for bilayer insertion. Nature 1995; 378 (6556):512-515.
211. Lyamuya EF, Moselle SY, A faire R. Placental transfer of IgG subclasses in a tropical population. Tanzania Med J1994; 9 (1):19-22.
212. Ma ASP, Bell DJ, Mind AA, Harrison HH. Immunocytochemical detection of extracellular annexin II in cultured human skin keratinocytes and isolation of annexin II isoforms enriched in the extracellular pool. J Cell Sci 1994; 107:1973-1984.
213. Mailliard WS, Haigler HT, Schlaepfer DD. Calcium-dependent binding of S100C to the N-terminal domain of annexin I. J Biol Chem 1996; 271 (2):719-725.
214. Makiya R, Stigbrand T. Placental alkaline phosphatase as the placental IgG receptor. Clin. Chem. 1992; 38 (12):2543-2545.
215. Makiya R, Stigbrand T. Placental alkaline phosphatase has a binding site for the human immunoglobulin-G Fc portion. Eur. J. Biochem. 1992; 205:341-345.
216. Makiya R, Thornell LE, Stigbrand T. Placental alkaline phosphatase, a GPI-anchored protein, is clustered in clathrin-coated vesicles. Biochem Biophys Res Commun 1992; 183 (2):803-808.
217. Malassine A, Besse C, Roche A, et al. Ultrastructural visualization of the internalization of low density lipoprotein by human placental cells. Histochemistry 1987; 87 (5):457-464.
218. Malek A, Sager R, Schneider H. Maternal Fetal Transport of Immunoglobulin-G and Its Subclasses During theThird Trimester of Human Pregnancy. Am J Reprod Immunol 1994; 32:8-14.
219. Malek A, Sager R, Zahker A, Schneider H. Transport of immunoglobulin G and its subclasses across the in vitro-perfused human placenta. Am J. Obstet Gynecol 1995; 173 (3):760-767.
220. Manaseki S, Searle RE Natural killer (NK) cell activity of first trimester human decidua. Cell Immunol 1989; 121 (1):166-173.
221. Manning JP, Inglis NR, Green S, Fishman WH. Characterization of placental alkaline phosphatase from three primates: African Green, and rhesus monkey and baboon. Enzymologia 1969; 37:251-261.
222. Matre R. Similarities of Fey Receptors on trophoblasts and placental endothelial cells. Scand J Immunol 1977; 6:954-958.
223. Matre R, Hangen A. The placental Fc receptors studied using immune complexes of peroxidase. Scand J. Immunol. 1978; 8:187-193.
224. Matre R, Haaheim LR, Tender O. A monoclonal antibody inhibiting human placental Fey-receptor activity. Int. Arch. Allergy Appl. Immunol. 1984; 75:227-229.
225. Matre R. Johnson PM. Multiple Fc receptors in the human placenta. APMIS 1977; 85:314-316.
226. Maire R, Kleppe G, Tender O. Isolation and characterization of Fey receptors from human placenta. Acta Pathol Microbiol Scand Sect C 1981; 89:209-231.
227. Maire R, Kristoffersen EK, Ulvestad E, Vedeler CA. Purification of a functional 40 kD human placental Fcg receptor using a monoclonal antibody. APMIS1989; 97:733-737.
228. Matre R, Tender O, Endresen C. Fc receptors in human placenta. Scand. J. Immunol. 1975; 4:741-745.
229. Matsuzaki N, Okada T, Kameda T, Negoro T, Saji F, Tanizawa O. Trophoblast-derived immunoregulatory factor: demonstration of the biological function and the physicochemical characteristics of the factor derived from choriocarcinoma cell lines. Am J Reprod Immunol 1989; 19 (4):121-127.
230. McCormick JN, Faulk WP, Fox H, Fudenberg HH. Immunohistological and elution studies of the human placenta. J Exp Med 1971; 133(1):1-18.
231. McCormick JN, Faulk WP, Fox H, Fudenberg HH. Immunohistological and elution studies of the human placenta. J Exp Med 1978; 133:1-18.
232. McKay DG, Hertig AT, Adams EC, Richardson MV. Histochemical observations on the human placenta. Obstet Gynecol 1958; 12(1):1-36.
233. McNabb T, Koh TY, Donington KJ, Painter RH. Structure and function of immunoglobulin domains: V. Binding of immunoglobulin G and fragments to placental membrane preparations. J. Immunol. 1976; 117 (3):882-888.
234. Medawar PR Some Immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol 1953; 7:320-338.
235. Mellman I, Fuchs R, HeleniusA. Acidification of the endocytic and exocytic pathways. Ann Rev Biochem 1986; 55:663-700.
236. Miettinen HM, Rose JK, Mellman I. Fc receptor isoforms exhibit distinct abilities for coated pit localization as a result of cytoplasmic domain heterogeneity. Cell 1989; 58 (2):317-327.
237. Mikuhka J, Boratynski J, Niezgodka M, LisowskiJ. Human placental membrane receptor for IgG, purification of the receptor and its subunit structure. Immunol lett 1982; 5:137-143.
238. Mikulska J, Lisowski J. Polyclonal antibodies directied against human placental Fey receptor characterization of the antibodies and their interaction with the receptor. Arch Immunol Ther Exp (Warz) 1987; 35:819-839.
239. Millan JL. Molecular cloning and sequence analysis of human placental alkaline phosphatase J Biol Chem 1986; 261 (7):3112-3115.
240. Miller ME, Mellman, Cohen MM, Kohn G, Dietz WH Jr. Depressed immunoglobulin G in newborn infants with Down's syndrome. J Pediatr 1969; 75 (6):996-1000.
241. Minami H, Tokumitsu H, Mizutani A, Watanabe Y, Watanabe M, Hidaka H. Specific binding of CAP-50 to calcyclin. FEBS Lett 1992; 305 (3):217-219.
242. Morell A, Skvaril F, Hitzig WH, Barandum S. IgG subclasses: Development of the serum concentrations in "normal" infants and children. J Pediatr 1972; 80 (6):960-964.
243. Morell A, Skvaril F. van Loghem E, Kleemola M. Human IgG subclasses in maternal and fetal serum.Vox Sang 1971; 21:481-492.
244. Morell A, Terry WD, Waldmann TA. Metabolic properties of IgG subclasses in man. J Clin Invest 1970; 49:673-680.
245. Morgan RO, Fernandez MP. Molecular phytogeny of annex-ins and identification of a primitive homologue in Giardia lamblia. Mol Biol Evol 1995; 12 (6):967-979.
246. Morris IG. An immunofluorescence study of IgG receptors in rodent enterocytes. Immunology 1980; 40:273-280.
247. Moskalewski S, Ptak IV, Czarnik Z. Demonstration of cells with IgG receptor in human placenta. Biol Neotane 1975; 26:268-273.
248. Moss DW. Perspectives in alkaline phosphatase research. Clin Chem 1992; 38 (12):2486-2492.
249. Moss SE. Ion channels - Annexins taken to task. Nature 1995; 378 (6556):446-447.
250. Moslov KE. Transepithelial transport of immunoglobulins. Annu. Rev. Immunol. 1994; 12:63-84.
251. Mostov KE, Sinister NE. Transcytosis. Cell 1985; 43 (2 Pt 1):389-390.
252. Nelson DM, Smith RM, Jarelt L. Nonuniform distribution and grouping of insulin receptors on the surface of human placental syncytial trophoblast. Diabetes 1978; 27 (5):530-538.
253. Nicholas NS, Panayi GS. Inhibition of interleukin-2 production by retroplacental sera: a possible mechanism for human fetal allograft survival. Am J Reprod Immunol Microbiol 1985; 9(1):6-11.
254. Niezgodka M, Mikulska J, Ugorski M, Boralynski J. Lisowski J Human placental membrane receptor for IgG: I. Studies on properties and solubilization of the receptor. Mol. Immunol. 1981; 18:163-172.
255. Nishikiori N, Koyama M, Kikuchi T, et al Membrane-spanning Fey receptor III isoform expressed on human placental trophoblasts. Am. J. Reprod. Immunol. 1993; 29:17-25.
256. Nishino E, Matstizaki N, Masuhiro K, eld. Trophoblast-derived interleukin-6 (IL-6) regulates human chorionic gonadotropin release through IL-6 receptor on human trophoblasts. J Clin Endocrinol Metab 1990; 71 (2):436-441.
257. Naschel H, Kuhnen A. Nachweis von Antikorpern gegen Plazentagewebe bei normalen Schwangsrschaften und bei Spattoxikosen. Zentralbl Gynakol 1970; 92 (42):1384-1390.
258. Nasche! H, Stelzner A, Seeu-ald H-J, Klinger G. Untersuchungen zur Plazentapassage von Virus-Antikorpern und immunoglobulinen an der in vitro perftmdierten menschlichen Plazenta. Zentralblatt fur Gynakologie 1975; 97 (3):180-184.
259. Ogbimi AO, Johnson PM, Brown PJ, Fox H. Characterisation of the soluble fraction of human syncytiotrophoblast microvillous plasma membrane-associated proteins. J Reprod Immunol 1979; 1:127-140.
260. Pampfer S, Dailer E, Barad D, Pollard JW. Expression of the colony-stimulating factor-1 receptor (c-fms proto-oncogene product) in the human uterus and placenta. Biol Reprod 1992; 46 (1):48-57.
261. Pearse BMF. Coated vesicles from human placenta carry ferritin, transferrin, and immunoglobulin G. Proc Natl Acad Sci USA 1982;79:451-455.
262. Pfäffle M, Ruggiero F, Hofmann H, et al. Biosynthesis, secretion and extracellular localization of anchorin CII, a collagen-binding protein of the calpactin family. EMBO J. 1988; 7:2335-2342.
263. Pitcher-Wilmott RW, Hindoclia P, Wood BS. The placental transfer of IgG subclasses in human pregnacy. Clin. exp. Immunol. 1980; 41:303-308.
264. Polano O. Der Antitoxinübergang von der Mutter auf das Kind. Ein beitrag zur Physiologie der Placenta. Z Geburtsh Gynäk 1904; 53:456-476.
265. 2+ channels in phosphatidylserine bilayer membranes. Proc Natl Acad Sci USA 1988; 85 (9):2974-2978.
266. Pollard JW. Lymphohematopoietic cytokines in the female reproductive tract. Curr Opin Immunol 1991; 3 (5):772-777.
267. 2+-binding proteins. Nature Struct Biology 1995; 2 (9):790-796.
268. Raghavan M, Bonagura VR, Morrison SL, Bjorkman PJ. Analysis of the pH dependence of the neonatal Fc receptor immunoglobulin G interaction using antibody and receptor variant. Biochemistry 1995; 34 (45):14649-14657.
269. Raghavan M, Chen MY, Gastinel LN, Bjorkman PJ. Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand. Immunity 1994; 1(4):303-315.
270. Raghavan M, Wang YP, Bjorkman PJ. Effects of receptor dimerization on the interaction between the class I major histocompatibility complex- related Fc receptor and IgG. Proc Natl Acad Sci USA 1995; 92 (24):11200-11204.
271. Rand JH, Wit XX, Guller S, et al. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am. I Obstet. Gynecol. 1994; 171 (6):1566-1572.
272. Rao CV, Ramani N, Chegini N, et al. Topography of human placental receptors for epidermal growth factor. J Biol Chem 1985; 260 (3):1705-1710.
273. Ravanat C, Archipoff G, Beretz A. Freund G, Cazenave JP, Freyssinet JM. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells. Biochem J1992; 282 (Ptl):7-13.
274. Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Bioch. Biophys. Acta 1994; 197:6393.
275. Redlitz A, Plow EF. Receptors for plasminogen and t-PA: an update. Baillieres Clin Haematol 1995; 8 (2):313-327.
276. Redman CW, Mc Michael A J, Stirrat CM, Sunderland CA, Ting A. Class 1 major histocompatibility complex antigens on human extra-villous trophoblast. Immunology 1984; 52 (3):457-468.
277. Rees AR, Wallace KH. Approaches to structural studies on Fc receptors. In: Hemmings WA, ed. In: Protein transmission through living membranes. Amsterdam: Elsevier/ North Holland. Amsterdam, New York, Oxford: Elsevier/ North Holland Biomedical Press, 1979:119-129.
278. Reeves SA, Chaves-Kappel C, Davis R, Rosenblum M, Israel MA. Developmental regulation of annexin II (Iipocortin2) in human brain and expression in high grade glioma. Cancer Res. 1992; 52:6871-6876.
279. Regnouf F, Sagot I, Delonche B, et al. "in vitro" phosphorylation of annexin 2 heterotetramer by protein kinase C Comparative properties of the unphosphorylated and phosphorylated annexin 2 on the aggregation and fusion of chromaffin granule membranes. J Biol Chem 1995; 270 (45):27143-27150.
280. Remade Bonnet MM, Ranee RJ, Depieds RC. Non-specific immunoregulatory factors in the cytosol fraction of human trophoblast. J Reprod Immunol 1983; 5 (3):123-134.
281. Roberts DM, Guenthert M, Rodewald R. Isolation and characterization of the Fc receptor from the fetal yolk sac of the rat. J Cell Biol 1990; 111 (5 Pt 1):1867-76.
282. Rocha V, Lozano JJ, Haindl AH. Evidence for differential localization of annexin VI during mammary secretory differentiation. Biochem SocTrans 1990; 18 (6):1110-1113.
283. Rodewald R. Selective antibody transport in the proximal small intestine of the neonatal rat. J Cell Biol 1970; 45 (3):635-640.
284. Rodewald R. pH-dependent binding of immunoglobulins to intestinal cells of the neonatal rat. J Cell Biol 1976; 71:666-670.
285. Rodewald R, Kraehenbuhl JP. Receptor-mediated transport of IgG. J Cell Biol 1984; 99 (1 Pt 2):159s-164s.
286. Rojas E, Pollard HB, Haigler HT, Parra C, Burns AL. Calcium-activated endonexin II forms calcium channels across acidic phospholipid bilayer membranes. J Biol Chem 1990; 265 (34):21207-2115.
287. Romisch J. Schuler E, Bastion B, et al. Annexins I to VI: quantitative determination in different human cell types and in plasma after myocardial infarction. Blood Coagul. Fibrinolysis 1992;3:11-17.
288. Rood GGv, Eernisse G, Van Leuween A. Leucocyte antibodies in sera from pregnant women. Nature 1958; 181:1735-1736.
289. Roseman BJ, Bollen A, Hsu J, Lamborn K, Israel MA. Annexin II marks astrocytic brain tumors of high histologic grade. Oncol Res 1994; 6 (12):561-567.
290. Rubenstein A, Koren Z, Murphy RA. Suppression of maternal lymphocyte mitogenic response by supernatants from short term placental cell cultures. Am. J. reprod. Immunol. 1982; 2:260-264.
291. Sajl F, Koyama M, Kameda T, Negoro T, Nakanmro K, Tanizawa O. Effect of a soluble factor secreted from cultured human trophoblast cells on in vitro lymphocyte reactions. Am J Reprod Immunol Microbiol 1987; 13 (4):121-124.
292. Saji F, Koyama M, Matsuzaki N. Current topic: human placental Fc receptors. Placenta 1994; 15 (5):453-66.
293. Sargent IL. Maternal and fetal immune response during pregnancy. Exp. Clin. Immunogenet. 1993; 10:85-102.
294. Sargent IL, Arenas J, Redman CW. Maternal cell-mediated sensitisation to paternal HLA may occur, but is not a regular event in normal human pregnancy. J Reprod Immunol 1987; 10 (2):111-20.
295. Schlaepfer DD, Haigler HT. Expression of annexins as a function of cellular growth state. J.Cell Biol. 1990; 111:229-238.
296. Schmidt W. The amniotic fluid compartment: the fetal habitat. Adv Anat Embryol Cell Biol 1992; 127:1-100.
297. Schnitzer JE, Liu J, Oh P. Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases. J Biol Chem 1995; 270 (24):14399-14404.
298. Schur PH, Alpert E, Alper C. y G subgroups in human fetal, cord, and maternal sera. Clin Immunol Imraunopathol 1973;2:62-66.
299. Schwanz Albiez R, Koretz K, Moller P. Wirl G. Differential expression of annexins I and II in normal and malignant human mammary epithelial cells. Differentiation 1993; 52 (3):229-237.
300. Sedmak DD, Davis DH, Singh U, van de Winkel JG, Anderson CL. Expression of IgG Fc receptor antigens in placenta and on endothelial cells in humans. An immunohisto-chemical study. Am. J. Pathol. 1991; 138:175-181.
301. Siiteri PK, Febres F, Clemens LE, Chang RJ, Gondos B, Stiles D. Progesterone and maintenance of pregnancy: is progesterone nature's immunosuppressant? Ann N Y Acad Sci 1977; 286:384-397.
302. Simister N, Rees AR. Isolation and characterization of an Fc receptor from neonatal rat small intestine. Eur. J. Immunol. 1985; 15:733-738.
303. Simister NE. Transport of monomeric antibodies across epithelia. Am. Soc. for Microbiol, 1990:57-73. (Metzger H, ed. Fc receptors and the action of antibodies;
304. Simister NE, Chen H-L, Story CM, Hunt JS. Localization of the neonatal Fc receptor in human placenta. IX International Immunology Conference. San Francisco Abstract Book 1995:p 191.
305. Simister NE, Mostov KE. Cloning and expression of the neonatal rat intestinal Fc receptor, a major histocompatibility complex class I antigen homolog. Cold Spring Harb Symp Quant Biol 1989; 54 Pt 1:571-580.
306. Simister NE, Mostov KE. An Fc receptor structurally related to MHC class I antigens. Nature 1989; 337:184-187.
307. Simister NE, Story CM. Fcγ receptors in human placenta. In: van de Winkel JGJ, Capel P, eds. Human IgG Fc receptors. Austin: CRC Press, 1996; Chapt. 2:25-38.
308. Simmons D, Seed B. The Fey receptor of natural killer cells is a phospholipid-linked membrane protein. Nature 1988; 333:568-570.
309. Simmons RL, Russell PS. The histocompatibility antigens of fertilized mouse eggs and trophoblast. Ann NY Acad Sci 1966; 129:35-45.
310. Skeie Jensen TS, Matre R. Feγ-receptor activity in the developing human placenta. APMIS1995; 103 (6):433-438.
311. Smith NC, Brush MG, Lucken S. Preparation of human placental villous surface membrane. Nature 1974; 252:302-303.
312. Smith PD, Moss SE. Structural evolution of the annexin supergene family. Trends in Genetics 1994; 10 (7):241-246.
313. Snary D, Woods FR, Crwnpton MJ Disruption of solid tissue for plasma membrane preparation. Anal Biochem 1976; 74 (2):457-465.
314. 2+-dependent binding of annexin IV to surfactant protein A and lamellar bodies in alveolar type II cells. Biochem J 1995; 312 (Part 1):175-181.
315. Sooranna SR, Contractor SF. Vectorial transcytosis of immunoglobulin G by human term trophoblast cells in culture. Exp. Cell Res. 1991; 192:41-45.
316. Sooranna SR, Moss J, Contractor SF. Comparison of the intracellular pathways of immunoglobulin-G and low density lipoprotein in cultured human term trophoblastcells. Cell Tissue Res. 1993; 274:619-625.
317. Sopkova J, Renouard M, Lewit Bentley A. The crystal structure of a new high-calcium form of annexin V. IMol.Biol. 1993; 234:816-825.
318. Soric J, Gordon JA. The 36-kilodalton substrate of pp60vsrc is myristylated in a transformation-sensitive manner. Science 1985; 230 (4725):563-566.
319. Starkey PM, Sargent IL, Redman CW. Cell populations in human early pregnancy decidua: characterization and isolation of large granular lymphocytes by flow cytometry. Immunology 1988; 65 (1):129-134.
320. Stengelin S, Stamenkovic I, Seed B. Isolation of cDNAs for two distinct human Fc receptors by ligand affinity cloning. EMBO J. 1988; 7:1053-1059.
321. Story CM, Mikulska JE, Simister NE. A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus. J. Exp. Med. 1994; 180 (6):2377-2381.
322. Strauss F. Die normale anatomic der menschlichen Placenta. Handbuch der patologischen Anatomie 1967; 7 (5):1-96.
323. Stuart SG, Simister NE, Clarkson SB, Kacinski BM, Shapiro M, Mellman I. Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium. Embo J 1989; 8 (12):3657-3666.
324. Sunderland CA, Naiem M, Mason DY, Redman CWG. Stirrat GM. The expression of major histocompatibility antigens by human chorionic villi. J. Reprod. Immunol. 1981; 3:323-331.
325. 2+-bridging mechanism and phospholipid head group recognition in the membrane-binding protein annexin V. Nature Struct Biology 1995; 2 (11):968-974.
326. Swairjo MA, Seaton BA. Annexin structure and membrane interactions: a molecular perspective. Annu Rev Biophys Biomol Struct 1994; 23:193-213.
327. Tait JF, Gibson D, Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem 1989; 264 (14):7944-7949.
328. Tait JF, Sakata M, McMullen BA, et al Placental anticoagulant proteins: Isolation and comparative characterization of four members of the lipocortin family. Biochem. 1988; 27:6268-6276.
329. Takahasln S, Reddy SV, Chirgwin JM, et al. Cloning and identification of annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption. J Biol Chem 1994; 269 (46):28696-28701.
330. Takeuchi S. Is production of blocking antibodies in successful human pregnancy an epiphenomenon? Am J Reprod Immunol 1990; 24 (4):108-119.
331. Tarare JM, Holmes CH. Differential expression of the receptors for epidermal growth factor and insulin in the developing human placenta. Cell Signal 1989; 1 (1):55-64.
332. Tedesco F, Radillo O, Candussi G. Nazzaro A, Mollnes TE, Pecorari D. Immunohistochemical detection of terminal complement complex and S protein in normal and preeclamptic placentae. Clin Exp Immunol 1990; 80 (2):236-240.
333. Thaler CJ, McIntyre JA, Fatilk WP. Fcreceptorandtrophoblast antigens in seminal plasma: a potential stimulus to prime mothers for implantation. Immunol. Lett. 1990; 26 (2):145-51.
334. Thong YH. Clinical value of IgG subclass investigations in pediatric practice. Pediatr Infect Dis J 1990; 9 (8 Suppl):s36-s40.
335. Toth FD, Mosborg Petersen P, Kiss J, et al. Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in vitro. Clin. Exp. Immunol. 1994; 96:389-394.
336. Tsao FH. Purification and characterization of two rabbit lung Ca2 (+)-dependent phospholipid-binding proteins. Biochim Biophys Acta 1990; 1045 (1):29-39.
337. Tsunoo H, Sussman HH. Characterization of transferrin binding and specificity of the placental transferrin receptor. Arch Biochem Biophys 1983; 225 (1):42-54.
338. Ugele B, Kuss E. Primary cultures of cytotrophoblasts as a model system to characterize the syncytial IgG-transport of human placenta. Deutsche Gesellschaft für Zellbiologie. Gottingen: Eur J Cell Biol, 1991:19.
339. Uh-estad E, Kristoffersen EK, Skeie Jemen T, Maire R. Identification of a soluble human Fey receptor (annexin II) using a competitive ELISA. APMIS1994; 102:667-673.
340. van de Winkel JG, Anderson CL. Biology of human immunoglobulin G Fc receptors. J Leukoc Biol 1991; 49 (5):511-524.
341. van de Winkel JG, Capel PJ. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol.Today 1993; 14:215-221.
342. van de Winkel JG, van Ommen R, Huizinga TW. et al. Proteolysis induces increased binding affinity of the monocyte type II FcR for human IgG. Jlmmunol. 1989; 143:571-578.
343. van der Meiden JA. McNabb TC. Haeffner-Cavaillon N, Klein M, Dorrington KJ. The Fey receptor on human placental plasma membrane: Studies on the binding of homologous and heterologous immunoglobulin G. J. Immunol. 1980; 124 (2):500-507.
344. Virella G, Amelia Silveira Nunes M, Tamagnini G. Placental transfer of human IgG subclasses. Clin. exp. Immunol. 1972; 10:475-478.
345. Vislmanatha JK, Chiang Y Kumble KD, Hollingsworth MA, Pour PM. Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis 1993; 14:2575-2579.
346. Vislmanatha JK, Kumble S. Involvement of annexin II in DNA replication: evidencefrom cell-free extracts ofXenopus eggs. J.Cell Sci. 1993; 105:533-540.
347. Voges D, Berendes R, Burger A, Demange P, Baumeister W, Huber R. Three-dimensional structure of membranebound annexin V. A correlative electron microscopy-X-ray crystallography study. J Mol Biol 1994; 238 (2):199-213.
348. Wainwright SD, Holmes CH. Distribution of Fey receptors on trophoblast during human placental development: an immunohistochemical and immunoblotting study. Immunology 1993; 80:343-351.
349. Waisman DM. Annexin II tetramer: Structure and function. Mol Cell Biochem 1995; 149:301-322.
350. Wallace KH. Rees AR. Studies on the immunoglobulin-G Fc-fragment receptor from neonatal rat small intestine. Biochem J1980; 188 (1):9-16.
351. Wang AC, Faulk WP. Stuckey MA, Fudenberg HH. Chemical differences of adult, fetal and hypogammaglobulinemic IgG immunoglobulins. Immunochemistry 1970; 7:703-708.
352. Wasz-Höckert O, Wager O, Hautala T, Wodholm O. Transmission of antibodies from mother to fetus. Ann Med Exp Biol Fennicae 1956; 34:444-446.
353. Watabe H, Gillin JI, Gitlin D. Further characterization of IgG receptors from human placenta. J. Biochem. 1980; 87:393-397.
354. Watts C. Rapid endocytosis of the transferrin receptor in the absence of bound transferrin. J Cell Biol 1985; 100 (2):633-637.
355. Webb PD, Evans PW, Molloy CM, Johnson PM. Biochemical studies of human placental microvillous plasma membrane proteins. Am. J. Reprod. Immunol. Microbiol. 1985; 8:113-119.
356. Webb PD. McLaughlin PJ, Risk JM, Johnson PM. Isolation of placental-type alkaline phosphatase associated with human syncytiotrophoblast membranes using monoclonal antibodies. Placenta 1986; 7:405-415.
357. Wegmann TG, Singh B, Carlson GA. Allogeneic placenta is a paternal strain antigen immunoabsorbent. J Immunol 1979; 122(1):270-274.
358. Weng X. Luecke H, Song IS, Kang DS, Kim SH, Huber R. Crystal structure of human annexin I at 2.5 A resolution. Protein Sci. 1993; 2:448-458.
359. Whyte A, Lake YW. Antigens of the human trophoblast plasma membrane. Clin Exp Immunol 1979; 37 (2):359-366.
360. Wild AE. Role of the cell surface in selection during transport of proteins from mother to foetus and newly born. Philos Trans R Soc Lond B Biol Sci 1975; 271 (912):395-410.
361. Wild AE. Endocytic mechanisms in protein transfer across the placenta. Placenta 1981; suppl. 1:165-186.
362. Winkel CA, Gilmore J, MacDonald PC, Simpson ER. Uptake and degradation of lipoproteins by human trophoblastic cells in primary culture. Endocrinology 1980; 107 (6):1892-1898.
363. Wislocki GB, Dempsey EW. Histochemical age-changes in normal and pathological placental villi (hydatiform mole, eclampsia). Endocrinol 1946; 38:90-109.
364. Wood G, Reynard J, Krishnan E, Racela L. Immunobiology of the human placenta. I. IgGFc receptors in trophoblastic villi. Cell Immunol 1978; 35 (1):191-204.
365. Wood GW, Johnson B, Halsey JF, King CR. Expression of Fey binding sites on human extraplacental membranes. Am J Reprod Immunol 1983; 4 (1):21-26.
366. Wood GW, King CR.Trapping antigen-antibody complexes within the human placenta. Cell Immunol 1982; 69:347-362.
367. Wright JF, Kurosky A, Wasi S. An endothelial cell-surface form of annexin II binds human cytomegalovirus. Biochem Biophys Res Commun 1994; 198 (3):983-989.
368. Yeatman TJ, Nicolson GL. Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis. Semin. Surg. Oncol. 1993; 9:256-263.
369. Yealman TJ, Updyke TV, Kaetzel MA, Dedman JR, Nicolson GL. Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cells. Clin. Exp. Metastasis 1993; 11:37-44.
370. Yelavarthi KK, Fishback JL, Hunt JS. Analysis of HLA-G mRNA in human placental and extraplacental membrane cells by in situ hybridization. J. Immunol 1991; 146 (8):2847-2854.
371. Yoshizaki H, Hashimolo Y, Arai K, et al. Phospholipid-binding properties of calphobindin-II (annexin VI), anticoagulant protein from human placenta. Chem Pharm Bull Tokyo 1991; 39 (10):2617-2621.
372. Zak SJ, Good RA. Immunochemical studies of human serum γ globulins. J Clin Invest 1959; 38:579-586.
373. 2-microglobulin deficient mice lack CD4-8+ cy-tolyticT cells. Nature 1990; 344 (6268):742-746.
374. Aarli A, Skeie Jensen T, Ulvestad E, Matre R. Suppression of mitogen-induced lymphoproliferation by soluble IgG Fc receptors in retroplacental serum in normal human pregnancy. Scand. J. Immunol. 1993; 37:237-243.
375. Aarli Å, Kristoffersen EK, Skeie Jensen T, Uhestad TE, Matre R. Suppression of lymphoproliferation by soluble annexin II released from isolated placental membranes. Manuscript.